Searchable abstracts of presentations at key conferences in endocrinology

ea0016p581 | Paediatric endocrinology | ECE2008

Successful treatment of isolated growth hormone deficiency type 1a with recombinant human growth hormone

Wessel Theda , Schnabel Dirk , Krude Heiko , Gruters Annette

Isolated growth hormone deficiency (IGHD) type 1a is caused by defects of the GH-I gene resulting in severe short stature. Treatment with growth hormone may become ineffective due to significant production of growth hormone antibodies. However, this has only been reported in patients treated with pituitary derived growth hormone. We present five cases with IGHD type 1a successfully treated with recombinant human growth hormone (rhGH).Five patients from f...

ea0016p598 | Paediatric endocrinology | ECE2008

Aspects and features of type 2 diabetes and the metabolic syndrome in obese children and adolescents

Wiegand Susanna , Dannemann Almut , Galler Angela , Wessel Theda , Bickenbach Annika , Gruters Annette

Background: Obesity is a rising problem in developed and developing countries. Currently little is known about prevalence and prognosis of type 2 diabetes and the metabolic syndrome in obese children and adolescents in Europe.Patients and methods: About 491 obese children (mean-age 11.2 years; mean-BMI 30.3 kg/m2) were examined (lipid-profile; blood pressure, insulin-resistance1) and in 102 of them with risk factors for type 2 diabe...

ea0016p597 | Paediatric endocrinology | ECE2008

New clinical features and detailed genetic analysis of heterozygous 17q12 deletion syndrome, leading to loss of TCF2 and MODY5

Raile Klemens , Wessel Theda , Deiss Dorothee , Mueller Dominik , Horn Denise , Riebel Wolfgang , Ullmann Reinhard , Klopocki Eva , Grueters Annette

Objective: MODY5 is caused by abnormalities in the TCF2 gene encoding the transcription factor HNF1β. We investigated cases of MODY5 for the underlying type of TCF2 anomaly.Case presentations: From 623 children and adolescents with diabetes mellitus followed at our diabetes clinic in 2006, 64 were negative for islet cell autoantibodies (GAD, IA-2, ICA) within the first year of diagnosis and out of these, four patients presented clinica...